Lead intoxication amyotrophic lateral sclerosis;Intoxication au plomb et sclerose laterale amyotrophique

Revue Neurologique

Volumn 154, Issue 4, 1998, Pages 345-347

  Couratier, P ^a,b   Bernet Bernady, P ^a   Truong, T ^a   Lagrange, E ^a   Preux, P M ^a   Lachatre, G ^b   Vallat, J M ^a  

^a Service de Neurologie

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; SUCCIMER; CHELATING AGENT;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; COMORBIDITY; DISEASE COURSE; HUMAN; LEAD POISONING; MALE; CHEMICALLY INDUCED DISORDER; FEMALE; PATHOPHYSIOLOGY; TREATMENT OUTCOME; WATER SUPPLY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHELATING AGENTS; FEMALE; HUMANS; LEAD POISONING; SUCCIMER; TREATMENT OUTCOME; WATER SUPPLY;

EID: 0032059001     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. ARMON C., KURLAND L.T., DAUBE J.R., O'BRIEN P.C. (1991). Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology, 41: 1077-1084.
2. BARUAH J.K., RASOOL C.G., BRADLEY W.G., MUNSAT T.L., (1981). Retrograde axonal transport of lead in rat sciatic nerve. Neurology, 37: 612-616.
3. CONRADI S., RONNEVI L.O., VESTERBVERG O. (1978). Increased plasma level of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurq Psychiatry, 41: 389-393.
4. LANDRIGAN P.J., FROINES J.R., MAHAFFEY K.R. (1985). Body burden summary of epidemiological data on its relation to environmental sources and toxic effects. In Mahaffey K.R. (eds), Dietary and environmental lead human health effects pp: 421-451. Elsevier. New York.
5. LOUWERSE E.S., BUCHET J.P., VAN DIJK M., de JONG V.J., LAUWERYS R.R. (1995). Urinary excretion of lead and mercury after oral administration of meso-2,3-dimercaptosuccinic acid in patients with motor neurone disease. Int Arch Occup Environ Health, 67: 135-138.
6. MITCHELL J.D. (1987). Heavy metals and trace elements in amyotrophic lateral sclerosis. Neuro Clin, 5: 43-60.
7. PATTEN B.M. (1984). Mineral and metal metabolism in amyotrophic lateral sclerosis. In Rose F.C. (eds), Research progress in motor neurone disease, 189-227. Pitman Books. London.
8. PIERCE-RHULAND R., PATTEN B.M. (1984). Muscle metal in motor neuron disease. Ann Neurol, 8: 193-195.
9. SIMPSON J.A., SEATON D.A., ADAMS J.H. (1964). Response to treatment with chelating agents of anaemia, chronic encephalopathy, and myelopathy due to lead poisoning. J Neurol. Neurosurg Psychiatry, 26: 536-541.
10. STOBER T., STELTE W., KINZE K. (1983). Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis. J Neurol Sci, 61: 21-26.
11. STRICKLAND D., SMITH S.A., DOLLIFF G., GOLDMAN L., ROELOFS R.I. (1996). Amyotrophic lateral sclerosis and occupational history. A pilot case-control study. Arch Neurol, 53: 730-733.
12. YASE Y. (1996). Amyotrophic lateral sclerosis - causative role of trace elements. Nippon Rinsho, 54: 123-128.